Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Adult-onset Still's Disease
Welcome,
Profile
Billing
Logout
6 Companies
1 Product
1 Product
0 Mechanisms of Action
0 Trials
5 News
|
|||||||||
Kineret
(anakinra) /
SOBI
Trial completion, Enrollment change:
NordicAOSD05: Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
(clinicaltrials.gov) - Mar 6, 2017
P2
, N=23, Completed,
Sponsor: Helsinki University
Active, not recruiting --> Completed | N=60 --> 23
|
|||||||||
tadekinig alfa
(IL-18BP) /
AB2 Bio
Trial completion, Enrollment change:
Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
(clinicaltrials.gov) - Aug 30, 2016
P2
, N=23, Completed,
Sponsor: AB2 Bio Ltd.
Active, not recruiting --> Completed | N=60 --> 23 Recruiting --> Completed | N=30 --> 23
||||||||||
tadekinig alfa
(IL-18BP) /
AB2 Bio
New P2 trial:
Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
(clinicaltrials.gov) - Mar 25, 2015
P2
, N=30, Recruiting,
Sponsor: AB2 Bio Ltd.
|
|||||||||
Arcalyst
(rilonacept) /
Regeneron, Kiniksa
Trial completion:
Interleukin-1 Trap to Treat Autoinflammatory Diseases
(clinicaltrials.gov) - Mar 5, 2014
P2
, N=11, Completed,
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting --> Completed | N=30 --> 23 Active, not recruiting --> Completed